Facial Paresis Associated With Facial Nerve Dysfunction: Clinical Trials

1 trial for Facial Paresis Associated With Facial Nerve Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Facial Paresis Associated With Facial Nerve Dysfunction: new trials by email Literature Review of Facial Paresis Associated With Facial Nerve Dysfunction trials Research Report on Facial Paresis Associated With Facial Nerve Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis
OnabotulinumtoxinA Injectable Product, AbobotulinumtoxinA Injectable Product, Incobotulinumtoxin A Injectable Product - Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction
Phase 4CompletedUniversity of Utah712012-07-012017-07-31

Narrower conditions

Facial Asymmetry (1)  ·  Facial Nerve Injuries (1)  ·  Facial Paralysis (1)  ·  Synkinesis (1)

Broader conditions

Cranial Nerve Diseases (1)  ·  Cranial Nerve Injuries (1)  ·  Craniocerebral Trauma (1)  ·  Dyskinesias (1)  ·  Facial Nerve Diseases (1)  ·  Mouth Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Paralysis (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Stomatognathic Diseases (1)  ·  Trauma, Nervous System (1)  ·  Wounds and Injuries (1)

Interventions

Botulinum Toxins, Type A (1)  ·  abobotulinumtoxinA (1)  ·  incobotulinumtoxinA (1)

Sponsors

University of Utah (1)

Top investigators

Preston D Ward, MD (1)

Results publications

PMID 28973094